16+
Major trials tracked
GLP-1 & incretin therapies · Live ClinicalTrials.gov data
Mazdutide clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 mazdutide trials on ClinicalTrials.gov by enrolment, 5 of them actively recruiting. The next phase 3 primary completion among them is expected Aug 2026. Refreshed daily — add up to four competitors to compare pipelines side by side.
11
Phase 3 trials
5
Actively recruiting
Aug 2026
Next phase 3 primary completion
7,606
Participants across trials
Innovent Biologics (Suzhou) Co. Ltd.
Lead sponsor by trial count
mazdutide (16)9 active2021–2031
mazdutide
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
mazdutide
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese SubjectsP2
A Study of IBI362 in Chinese Patients With Type 2 DiabetesP2
A Study of IBI362 in Participants With Obesity or OverweightP3
A Study of IBI362 in Participants With Type 2 DiabetesP3
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseP3
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightP2
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightP2
A Study of IBI362 9 mg in Chinese Adults With ObesityP3
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and ObesityP3
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderP2
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）P3
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2P3
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)P3
A Study of IBI362 in Chinese Adolescents With Obesity or OverweightP3
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorP3
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityP3
Upcoming readouts
7 ahead · mazdutide
Select a trial to load its full ClinicalTrials.gov record.
Key mazdutide trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07469800 | Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity | Phase 3 | Recruiting | Aug 2026 |
| NCT06931028 | A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2 | Phase 3 | Recruiting | May 2027 |
| NCT07255209 | A Study of IBI362 in Chinese Adolescents With Obesity or Overweight | Phase 3 | Recruiting | Oct 2027 |
| NCT07083154 | GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) | Phase 3 | Recruiting | Aug 2029 |
| NCT06164873 | A Study of IBI362 9 mg in Chinese Adults With Obesity | Phase 3 | Active, not recruiting | Jun 2025 |
| NCT06884293 | A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-assoc… | Phase 3 | Active, not recruiting | Dec 2026 |
| NCT07417306 | A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodi… | Phase 3 | Not yet recruiting | Aug 2027 |
| NCT05607680 | A Study of IBI362 in Participants With Obesity or Overweight | Phase 3 | Completed | Aug 2023 |
| NCT05628311 | A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise | Phase 3 | Completed | Oct 2023 |
| NCT05606913 | A Study of IBI362 in Participants With Type 2 Diabetes | Phase 3 | Completed | Jan 2024 |
| NCT06184568 | A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity | Phase 3 | Completed | Sept 2025 |
| NCT06143956 | A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants W… | Phase 2 | Recruiting | Sept 2027 |
Related drug pipelines
FAQ
- How many clinical trials are running for mazdutide?
- ClinicalTrials.gov lists more than 16 phase 2–4 mazdutide trials. This page tracks the 16 largest by enrolment: 5 phase 2, 11 phase 3, and 0 phase 4 among them, with 5 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare mazdutide against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.